Riegel v. Medtronic, Inc.

Riegel v. Medtronic, Inc.

Argued December 4, 2007
Decided February 20, 2008
Full case name Charles R. Riegel, et ux. v. Medtronic, Inc.
Docket nos. 06-179
Citations

552 U.S. 312 (more)

Argument Oral argument
Holding
The MDA’s pre-emption clause bars common-law claims challenging the safety or effectiveness of a medical device marketed in a form that received premarket approval from the FDA.
Court membership
Chief Justice
John G. Roberts
Case opinions
Majority Scalia, joined by Roberts, Kennedy, Souter, Thomas, Breyer, Alito (in full); Stevens (all except for III-A and III-B)
Concurrence Stevens (in part)
Dissent Ginsburg

Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), is a United States Supreme Court case in which the Court held that the pre-emption clause of the Medical Device Amendment bars state common-law claims that challenges the effectiveness or safety of a medical device marketed in a form that received premarket approval from the Food and Drug Administration.

It modified the rule in Medtronic, Inc. v. Lohr, 518 U.S. 470 (1996).

See also

Further reading


This article is issued from Wikipedia - version of the Thursday, January 07, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.